黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 上海起發(fā)實(shí)驗(yàn)試劑有限公司

          當(dāng)前位置:> 供求商機(jī)> Ribosomal P antigen

          [供應(yīng)]Ribosomal P antigen

          貨物所在地:上海上海市

          產(chǎn)地:新西蘭

          更新時(shí)間:2024-10-11 21:00:07

          有效期:2024年10月11日 -- 2025年4月11日

          已獲點(diǎn)擊:184

          聯(lián)系我時(shí),請(qǐng)告知來(lái)自 化工儀器網(wǎng)

          Identity:Ribosomal P antigen, nRNP antigen.Source Material:Bovine thymus (New Zealand origin).Clinical Indications:Autoantibodies present in systemic lupus erythematosus.Ordering Information:ATR03-02

          RIBOSOMAL P ANTIGEN 
          AROTEC_RiboP_Product_Info.pdf Version/Date: B/04.05.25 
          ATR03-02 Ribosomal P antigen 0.20 mg 
          ATR03-05 Ribosomal P antigen 0.50 mg 
          ATR03-10 1.0 mg 
          _________________________________________________________________________________
          Description of the Product
          Purified from bovine thymus. After coating onto ELISA plates 
          the product will bind autoantibodies to ribosomal P antigen. 
          Purity: The ribosomal P antigen subunits P0, P1 and P2 (38, 
          19 and 17 kDa respectively) are more than 90% pure, as 
          assessed by SDS-polyacrylamide gel electrophoresis. 
          Concentration: 0.1-1.0 mg protein/ml. 
          Storage: The product is stabilised with 20% glycerol and 0.1% 
          Micr-O-protectTM. Store at -20 o
          C or below (long term) or at 
          +4o
          C (short term). Avoid repeated freezing and thawing. Mix 
          thoroughly before use. 
          Clinical and Biochemical Data 
          The existence of autoantibodies to ribosomal components has 
          been known for some time1,2. In 1985, two groups 
          independently identified the ribosomal P proteins as the major 
          protein antigens recognised by ribosomal antibodies3,4. Antiribosomal P antibodies are considered to be very specific for 
          systemic lupus erythematosus (SLE)5,6, and their presence 
          frequently correlates with disease activity, in particular 
          psychotic depression6
          , hepatitis7-9, and nephritis10,11. Although 
          anti-ribosomal P antibodies have been reported to occur in 
          patients with systemic sclerosis12, this would appear to be rare 
          and normally indicates an overlap with SLE13
          .
          The P proteins are three of approximay 80 proteins that 
          make up the largest cytoplasmic ribonucleoprotein, the 
          ribosome. Since ribosomes are assembled in the nucleoli, 
          high titre anti-ribosomal P sera will show nucleolar as well as 
          cytoplasmic immunofluorescent staining14. The exact functions 
          of the individual P proteins are not fully understood however 
          studies suggest that they collectively comprise part of a 
          functional GTPase domain necessary for the binding of factorGTP complexes15,16. This interaction results in catalysis of the 
          appropriate step of the protein synthesis cycle (initiation, 
          elongation or release). GTP is hydrolysed and the factor is 
          released. The ribosomal P proteins are distinctive through 
          their overall net negative charge, high content of alanine and 
          predicted secondary structure (approx. 70% helical)14. The Cterminal 17 amino acids of all three P proteins are virtually 
          identical and are highly conserved between species. Although 
          the major autoantibody epitope on all three proteins is 
          believed to be located within the C-terminal 22 amino 
          acids14,17, there is recent evidence that other individual P 
          protein-specific epitopes occur18

          The ribosomal P0, P1 and P2 proteins are all present in 
          AroTec’s ribosomal P antigen. The antigen typically exhibits a 
          260/280 nm absorbance ratio of >1.5, suggesting that a 
          significant rRNA component is present. The sequences of the 
          bovine P0 and P2 proteins have been determined19, and 
          found to be very homologous (>99%) to their human 
          equivalents20. In particular the C-terminal 22 amino acids of 
          both species were found to be identical. 
          Methodology
          The following is an ELISA procedure which can be used to 
          detect anti-ribosomal P autoantibodies in human serum using 
          the ATR03 purified autoantigen: 
          1. Dilute the purified antigen to 0.5-1.0 µg/ml in PBS (10 mM 
          potassium phosphate, pH 7.4, 0.15 M NaCl). 
          2. Coat ELISA plates with 100 µl of diluted antigen per well. 
          Cover and incubate 24 hours at +4o
          C. 
          3. Empty the plates and remove excess liquid by tapping on a 
          paper towel. 
          4. Block excess protein binding sites by adding 200 µl PBS 
          containing 1% BSA per well. Cover and incubate at +4o

          overnight. 
          5. Empty plates and apply 100 µl of serum samples diluted 
          1:100 in PBS / 1% BSA / 1% casein / 0.1% Tween?
           20. 
          Incubate at room temperature for 1 hour. 
          6. Empty plates and add 200 µl PBS / 0.1% Tween?
           20 per 
          well. Incubate 5 minutes then empty plates. Repeat this step 
          twice. 
          7. Apply 100 µl anti-human IgG-enzyme conjugate 
          (horseradish peroxidase or alkaline phosphatase) diluted in 
          PBS / 1% BSA / 1% casein / 0.1% Tween?
           20 per well and 
          incubate for 1 hour. 
          8. Repeat step 6. 
          9. Add enzyme substrate and stop the reaction when 
          appropriate. 
          10. Read absorbance in an ELISA spectrophotometer. 
          References 
          1. Sturgill, P.H. et al. (1965) Arthritis Rheum. 8, 213 
          2. Schur, P.H. et al. (1967) Immunochemistry 4, 447 
          3. Elkon, K.B. et al. (1985) J. Exp. Med. 162, 459 
          4. Francoeur, A.-M. et al. (1985) J. Immunol. 135, 2378 
          5. Elkon, K.B. et al. (1992) Rheum. Dis. Clin. 18, 377 
          6. Teh, L.S. & Isenberg, D.A. (1994) Arthritis Rheum. 37, 307 
          7. Koren, E. et al. (1993) Arthritis Rheum. 36, 1325 
          8. Hulsey, M. et al. (1995) Clin. Immunol. Immunopathol. 74, 252 
          9. Arnett, F.C. & Reichlin, M. (1995), Am. J. Med. 99, 465 
          10. Martin, A.L. & Reichlin, M. (1996) Lupus 5, 22 
          11. Sato, T. et al. (1991) J. Rheumatol. 18, 1681 
          12. Fujimoto, M et al. (1996) J. Dermatol. 23, 33 
          13. Fujimoto, M. et al. (1995) Br. J. Rheumatol. 34, 908
          14. Elkon, K.B. (1994) Man. Biol. Markers Dis. (Kluwer Acad. Publ.) 
           B2.5/1-11 
          15. Chu, J.L. et a l. (1991) J. Exp. Med. 174, 507 
          16. Teh, L.S. et al. (1992) Br. J. Rheumatol. 32, 287 
          17. Elkon, K. et al. (1986) Proc. Natl. Acad. Sci. USA 83, 7419 
          18. Fabien, N. et al. (1999) J. Autoimmun. 13, 103 
          19. SWISS-PROT RLA0_BOVIN primary accession number Q95140 & 
           RLA2_BOVIN primary accession number P42899 
          20. Rich, B.E. & Steitz, J.A. (1987) Mol. Cell Biol. 7, 4065 
          Micr-O-protect is from Roche Diagnostics GmbH (Mannheim, 
          Germany). 
          Tween?
           20 is a registered trademark of ICI Americas Inc. 
          NOTE: No patented technology has been used by AroTec 
          during the preparation of this product. 

          會(huì)員登錄

          X

          請(qǐng)輸入賬號(hào)

          請(qǐng)輸入密碼

          =

          請(qǐng)輸驗(yàn)證碼

          收藏該商鋪

          X
          該信息已收藏!
          標(biāo)簽:
          保存成功

          (空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

          常用:

          提示

          X
          您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~

          以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。

          溫馨提示:為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn),建議您在購(gòu)買(mǎi)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。

          撥打電話
          在線留言
          宜兰县| 周宁县| 邹城市| 科尔| 石城县| 聊城市| 商城县| 汕尾市| 定陶县| 汉沽区| 长顺县| 湖口县| 中宁县| 监利县| 张北县| 偃师市| 平武县| 黑山县| 上杭县| 汝阳县| 灵山县| 马尔康县| 托里县| 彰武县| 曲阳县| 大化| 丁青县| 旺苍县| 安丘市| 神池县| 靖远县| 吴川市| 林西县| 黑水县| 吕梁市| 光山县| 保定市| 江阴市| 确山县| 吉首市| 昌宁县|